RISE TO THE CHALLENGE

Philip Morris Products S.A. is seeking talented people to join our team in the Innovation Team in Neuchâtel, Switzerland.

You will be part of the PMI Research & Development Department, whose primary mission is to research and develop new products with the potential to reduce the risks of smoking-related diseases.

You will identify, assess and develop innovative technologies related to aerosolization systems that can be used in PMI’s Reduced Risk Products (RRPs).*

You will leverage your experience gained in other industry (pharmaceutical industry for example) to propose and select cutting edge technologies that are consumer relevant and can be implemented in RRPs. You will provide comprehensive technical assessment of new technologies by highlighting key benefits and potential risks.

FIND A NEW PATH

Our company offers you a fresh perspective. Here, you will never stop exploring and discovering. We take on-the-job learning to another level, giving you every opportunity to develop your career and reach your full potential. This position will advance your experience with innovative technologies, services, and processes. Backed by a competitive salary and compensation package, you will work in a professional setting with clients and team members from all over the world.

RESPONSABILITIES:

• Identify, evaluate and develop new technologies to generate aerosol.
• Leverage your external networks in the field of aerosol generation systems to develop working prototypes.
• Set up prototyping capability with externals to demonstrate new technology feasibility.
• Manage several internal and external projects in parallel.
• Find innovative solutions to improve and optimize product performance.
• Share project progress and outcome through scientific reports and presentations.

To submit your application, please click on the "Apply through website" button, and complete the registration page.

QUALIFICATIONS

• University/Engineering graduate or post-graduate in Mechanical or Electronic Engineering
• Substantial product development experience in industry is required ideally in the medical devices field
• Knowledge in mass and thermal transfers
• Experience in fast product prototyping
• Enthusiastic, creative and pragmatic individual who enjoys a challenging and international work environment
• Fluency in English both oral and written

You have excellent analytical skills that allow you to grasp the essence of complex issues. You have good customer service orientation, are ready to work efficiently within a multidisciplinary team and have good affinities with systems and integrated company processes. Furthermore, you are ready to work independently; under pressure and to handle multiple projects in parallel. You are flexible to travel several times a year and to handle peak activity periods. You possess good organizational skills.

Want to discover your potential? Come join our team!

A valid Swiss work permit or Swiss or EU-25/EFTA citizenship is required for this position.

JOIN A GLOBAL MARKET LEADER

Philip Morris International Inc. (PMI) is the leading international tobacco company, with seven of the world’s top 15 brands, including the number one cigarette brand worldwide. PMI’s products are sold in more than 180 Markets. In 2013, the company held an estimated 15.7% share of the total international cigarette market outside of the U.S., or 28.2% excluding the People’s Republic of China and the U.S. PMI is an Equal Opportunity Employer. For more information, seewww.pmi.com.

* Reduced-Risk Products ("RRPs") is the term the company uses to refer to products with the potential to reduce individual risk and population harm in comparison to smoking combustible cigarettes. PMI’s RRPs are in various stages of development, and we are conducting extensive and rigorous scientific studies to determine whether we can support claims for such products of reduced exposure to harmful and potentially harmful constituents in smoke, and ultimately claims of reduced disease risk, when compared to smoking combustible cigarettes. Before making any such claims, we will need to rigorously evaluate the full set of data from the relevant scientific studies to determine whether they substantiate reduced exposure or risk. Any such claims may also be subject to government review and approval, as is the case in the USA today